STOCK TITAN

If You Invested in Neolara Corp (NELR)

OTC
See the NELR overview
NELR has not traded since Aug 19, 2026. Its last close was $0.0250, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
N/A
Comparable prices start Jun 29, 2026
$1,000 invested 5 Years Before Its Last Close
N/A
Comparable prices start Jun 29, 2026
$1,000 invested 10 Years Before Its Last Close
N/A
Comparable prices start Jun 29, 2026

What $1,000 or $10,000 in NELR Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Jun 29, 2026
$1,000 — — — $12 -99%
$10,000 — — — $119 -99%

Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start NELR on Jun 29, 2026 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.

Custom Calculation

Choose your own date and amount for NELR

$1,000 Investment Over Time

NELR vs S&P 500

Year-by-Year Returns

NELR annual performance
Year Start Price End Price Annual Return Cumulative
2026Jun 29, 2026 to Aug 19, 2026 $2.10 $0.0250 -98.8% -98.8%

About Neolara Corp

OTC

Neolara Corp (symbol: NELR) is a corporation incorporated in the U.S. state of Wyoming, as disclosed in its reports filed under the Securities Exchange Act of 1934. According to an 8-K filed with the U.S. Securities and Exchange Commission, the company has a Commission File Number of 000-56687 and an Internal Revenue Service employer identification number of 98-1674969. While recent filings describe important corporate governance changes, they do not provide a detailed description of Neolara Corp’s operating business or industry classification.

The same 8-K filing lists a mailing location in Coto Brus, Puntarenas, Costa Rica, indicating that Neolara Corp maintains a connection to that region for corporate correspondence. However, the filing focuses on ownership and management changes rather than operational activities, and it does not specify the company’s sector, products, or services. As a result, publicly available regulatory information emphasizes Neolara Corp’s corporate structure and control rather than its day-to-day commercial operations.

Corporate control and governance

According to the 8-K dated September 19, 2025, a stock purchase agreement resulted in a change in control of Neolara Corp. The previous chief executive officer, director, and majority shareholder entered into an agreement to sell 2,000,000 shares of common stock, representing approximately 63% of the issued and outstanding common shares as of that date, to a new controlling shareholder, Cao Wei. This share transfer gives the buyer the ability to unilaterally influence the election of the board of directors and other matters requiring shareholder approval.

The same filing states that, effective on the date of the transaction, the prior executive officers and directors resigned from their positions, including roles such as Chief Executive Officer and President, and as members of the board. On that date, Cao Wei was appointed as Chief Executive Officer, Chief Financial Officer, Secretary, and sole Director of Neolara Corp. These disclosures highlight that the company’s governance is concentrated in a single individual following the reported change in control.

Board composition and professional backgrounds

The 8-K filing also provides background information about individuals associated with the board and management. It describes Cao Wei’s prior experience in architectural design and construction-related roles at several companies, as well as his Bachelor of Civil Engineering degree from Hubei University of Technology. This indicates that the controlling officer and director has a professional history in civil engineering and construction design.

In addition, the filing describes Li Yan as a director with experience in biomedical engineering roles, including positions focused on clinical validation of medical devices, product development, and technical support. Li Yan holds a Bachelor’s degree in Biomedical Engineering from Hubei University of Science and Technology. Another director, Lloveras Amador Ricardo, is described as having experience in software development and project management, including work on web applications, automated testing frameworks, and large-scale IT projects. He holds a Bachelor’s degree in Computer Engineering from the University of Barcelona.

These biographies show that Neolara Corp’s leadership and board-level participants have backgrounds spanning civil engineering, biomedical engineering, and software development. However, the 8-K does not state that Neolara Corp itself operates in these fields; it only documents the prior careers and education of the individuals involved.

Regulatory reporting and public company status

Neolara Corp files reports with the SEC under the Securities Exchange Act of 1934, as evidenced by the 8-K reports describing changes in control and management. The presence of a Commission File Number and the use of standard SEC item headings (such as Item 5.01 and Item 5.02) indicate that Neolara Corp is subject to ongoing reporting obligations. The filings focus on material events related to ownership and governance, which are key areas of interest for investors evaluating corporate control and board oversight.

Because the available filings do not describe the company’s revenue sources, business segments, or specific industry, investors researching Neolara Corp may rely heavily on these governance disclosures to understand who directs the company and how control is exercised. The concentration of ownership and management in a small group of individuals is a notable feature of the company’s current structure, as described in the 8-K.

Information limitations

Based on the information provided in recent SEC filings, Neolara Corp’s detailed business activities, sector classification, and product or service offerings are not specified. The filings instead emphasize corporate control, board composition, and the professional backgrounds of key individuals. As a result, any assessment of Neolara Corp using public regulatory documents will focus primarily on its status as a Wyoming corporation with a documented change in control and a board and management team whose experience spans engineering and software disciplines.

Prospective investors and researchers can use this information to understand the company’s legal jurisdiction of incorporation, the extent of ownership concentration, and the qualifications of its leadership, while recognizing that additional sources would be needed to obtain a full picture of Neolara Corp’s operational business model.

Last Close
$0.0250
Revenue (FY2025)
$0.0B
Net Margin (FY2025)
-81.3%
View full NELR overview

Frequently Asked Questions

Neolara Corp investment returns

How much was $1,000 invested in Neolara Corp worth at its last close?

Limited historical data is available for NELR. The prices we can compare start on 2026-06-29.

Has Neolara Corp outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare NELR performance over available time periods.

For informational and educational purposes only, not investment advice.